Bromfenac is a non-steroidal anti-inflammatory drug (NSAID) primarily used in ophthalmology for the treatment of postoperative inflammation and pain following cataract surgery. It is characterized by its ability to inhibit cyclooxygenase enzymes, which play a crucial role in the inflammatory process by converting arachidonic acid into prostaglandins. Bromfenac is typically formulated as an eye drop solution, allowing for localized treatment with minimal systemic absorption. The compound is known for its relatively rapid onset of action and prolonged therapeutic effects, making it effective in managing inflammation. Its chemical structure includes a bromine atom, which contributes to its pharmacological properties. Bromfenac is generally well-tolerated, though potential side effects may include ocular discomfort, burning, or stinging upon application. As with any medication, it is essential to follow dosing guidelines and consult healthcare professionals for appropriate use, especially in patients with pre-existing ocular conditions or those using other topical ophthalmic medications.

Bromfenac

91714-94-2: 2-(2-Amino-3-(4-bromobenzoyl)phenyl)acetic acid, 2-Amino-3-(4-bromobenzoyl)benzeneacetic acid, Ahr 10282, Benzeneacetic acid, 2-amino-3-(4-bromobenzoyl)-, Bromday, Bromfenac [INN], Bromfenaco, Bromfenaco [Spanish], Bromfenacum, Bromfenacum [Latin], Broxinac, Unii-864P0921Dw, Xibrom, [2-Amino-3-(p-bromobenzoyl)phenyl]acetic acid, Bromfenac

2-(2-Amino-3-(4-bromobenzoyl)phenyl)acetic acid

Cyclooxygenase inhibitor; NSAID; an opthalmic analgesic

Bromfenac, a potent COX inhibitor, targets ocular inflammation with IC50s of 5.56 nM for COX-1 and 7.45 nM for COX-2.

CAS 91714-94-2: Bromfenac

2-(2-Amino-3-(4-bromobenzoyl)phenyl)acetic acid

Ref: IN-DA006E4H

Bromfenac

Ref: 3D-FB66513

2-(2-Amino-3-(4-bromobenzoyl)phenyl)acetic acid

Ref: 10-F213485

Bromfenac

Ref: TM-T61010